Natera Inc (NAS:NTRA)
$ 124.39 0.95 (0.77%) Market Cap: 15.38 Bil Enterprise Value: 14.82 Bil PE Ratio: 0 PB Ratio: 18.35 GF Score: 72/100

Natera Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 08:55PM GMT
Release Date Price: $54.59 (+0.72%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Welcome, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure to host Natera today. And from the company, we have Steve Chapman, CEO; and Mike Brophy, CFO.

For important disclosures, please see the MS research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So Steve, lots to chat about, but maybe as you look back on the last 12 months, just to set the stage for us, what are the key accomplishments you're most proud of? And what are you most excited about heading into '24?

Steven Leonard Chapman
Natera, Inc. - CEO, President & Director

Yes. So great question. I think we've significantly advanced the ball forward across all 3 of the different areas

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot